An interventional study of Physical exercise in Psychosis, sponsored by Solli Distriktspsykiatriske Senter. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-24.
Sponsored by Solli Distriktspsykiatriske Senter · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Psychotic Disorders with a site in Norway — 6 open to participants now, 7 under way, none of them phase 3. Psychotic Disorders · Norway.
Among the 26 studies in Psychotic Disorders with a site in Norway, this one is the 16th largest by planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2022, is one of 12 with no phase, and was the 20th registered.
1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.
Browse Psychotic Disorders studies →6 of the 26 studies in Psychotic Disorders with a site in Norway are open now. Recruiting first, the newest first:
Philipp Homan · Sites in Norway, Czechia, Ireland and 3 more countries
Ages 18–65 · Healthy volunteers
Oslo University Hospital · Sites in Norway
Ages 17–65
Haukeland University Hospital · Sites in Norway
Ages 16+
Vestre Viken Hospital Trust · Sites in Norway
Ages 18+
Sykehuset i Vestfold HF · Sites in Norway
Ages 18–65
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 2 · Phase 4 4
First in 2001; this study’s year is marked. 1 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 65 across 1,326 interventional studies indexed under Psychotic Disorders.
Median enrollment 87 across the 20 interventional studies, 211 across the 6 observational. Of the 16 that completed or were terminated, 3 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 26 have an industry lead sponsor. The 10 most frequent:
Solli Distriktspsykiatriske Senter is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Solli Distriktspsykiatriske Senter has 1 study filed under Psychotic Disorders — fewer than ten, so there is no comparison to draw.
1 of the studies in Psychotic Disorders with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05719116Solli Distriktspsykiatriske SenterA Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 26 studies in Psychotic Disorders with a site in Norway, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is a feasibility study of a combined high intensity aerobic and strenght exercise program for persons with psychotic disorders. The feasibility of the protocol will be investigated, in addition to the participants subjective experience with the participation.
The aim of this study is to investigate the feasibility of a 16 week physical exercise intervention combining strenght and aerobic training in group for patients with psychotic disorders. In addition, the feasibility of the test protocol and participants subjective experience with the intervention will be investigated.
Research shows positive effects of physical exercise for patients with psychotic disorders regarding maximal aerob training, maximal muscle strength, physical, cognitive and social functioning, and symptom levels. Effects and the degree of feasibility of physical exercise for patients with psychotic disorders are amplified by regarding their preferences and needs, and if they experience support and guidance during the intervention. Earlier studies have focused mostly on either strength og endurance training, or combined interventions of moderate intensity. We now want to investigate the feasibility of an invidually adjusted combined program of high intensity.
After the intervention, participants will be interviewed about their experience with participating.
Participants with psychotic disorder:
Inclusion Criteria:
Exclusion Criteria:
Participants with psychiatric disorder, but no psychotic disorder:
Inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants with a psychotic disorder will exercise in a group supervised by a physiotherapist for 16 weeks, three times a week.
Behavioral: Physical exercise
Participants with a psychiatric disorder will exercise in a group supervised by a physiotherapist for 16 weeks, three times a week.
Behavioral: Physical exercise
The physical exercise will be aerobic and strength training. The sessions will last app. 1 hour.
Feasibility of the intervention program
How many participants completed the physical training intervention.
Time frame: After 16 weeks of intervention
Aerobic capasity: Ekblom Bak submaximal ergometer cycle test
Estimating Vo2max
Time frame: At week 0 and 16
Aerobic capasity: 4 x 4 interval for estimating VO2max
Standarised 4x4 interval training for estimating VO2max with the smartphone app My Workout GO
Time frame: At week 0 and 16
Strength: 1 RM test of bench press
Maximal test of strenght of upper body
Time frame: At week 0 and 16
Strenght: 1 RM test of squat
Maximal test of lower body musculature
Time frame: At week 0 and 16
Psychotic symptoms: The Positive and Negative Syndrome Scale
For the participants with psychotic disorders only. A measure of positive and negative psychotic symptoms. Each item is scored on a scale from 1-7 with a higher score indicating higher symptom level.
Time frame: At week 0 and 16
Depression symptoms: The Calgary Depression Scale for Schizophrenia
A measure of depressive symptoms. Each item is scored on a scale from 0-3 with a higher score indicating higher symptom level.
Time frame: At week 0 and 16
Anxiety symptoms: GAD-7
A measure of anxiety symptoms. This is a 7-item self-report questionnaire where participants rate on a scale from 0 (not at all sure) to 3 (nearly every day). A higher score indicates greater symptom severity.
Time frame: At week 0 and 16
Quality of life: SF-12
A measure of health related quality of life. The items is scored after variying categories such as "yes" and "no", and "How much time during the past 4 weeks...".
Time frame: At week 0 and 16
In depth interview
A semi structured interview for asking the participants about their experience with the intervention
Time frame: After 16 weeks of intervention
Plan to share: Yes — We plan to publish our results in peer-reviewed journals.
Supporting information: Study protocol, Statistical analysis plan
Time frame: We plan to publish the study protocol. The statistical analysis plan will be available in published articles.
Access criteria: After data collection has been completed, data can be available upon reasonable request.
No publications or documents are linked to this record.
Started Nov 2022 (actual). Primary completion is estimated for Dec 2026, 49 months after the start.
Of 460 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 49 months is above that.
Counting every sponsor, half of 462 studies reached it within 34 months; a quarter within 19 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Solli Distriktspsykiatriske Senter